Webinar: Health Canada GMP Inspections & Clinical Trials during COVID-19

Webinar: Health Canada GMP Inspections & Clinical Trials during COVID-19

June 11, 2020 1:00pm EDT – 1:00 pm - 2:10 pm

CAPRA is pleased to host a special COVID-19 related Webinar by Health Canada. Topics that will be addressed include:

1. Assessment of GMP compliance/remote GMP Inspections during the COVID-19 pandemic.
2. Management of Clinical Trials during the COVID-19 pandemic. 

Opening remarks   Dr. John Patrick Stewart, Director General Therapeutic Products Directorate, Health Products and Food Branch

Remote GMP inspections and how GMP compliance status will be addressed. If this situation continues for an extensive period of time what will be the impact/interface with drug (pharmaceuticals and biologics) submissions under review and impact in terms of ability to file where foreign site status may be expired.

Questions and answers

Kim Godard, Director
Health Product Inspection and Licensing, Health Product Compliance, Regulatory Operations and Enforcement Branch

Melanie Bhangoo, Manager, Inspections

Clinical Trials

Managing clinical trials during the COVID pandemic

 Questions and answers

Dr. Daniel Keene, Senior Medical Officer and Manager, Office of Clinical Trials for Biological Agents, Biologics and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch

Registrants will be sent an automated email with a link to register for the webinar once the online registration is complete.
Please add your First name, Last name and the Email address that you will use to log in the day of the webinar.
Registrants may be substituted, but no refunds will be issued after the deadline. 

Speakers / Panelists

Registration is now closed